SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567619-19-012688
Filing Date
2019-06-04
Accepted
2019-06-04 16:57:58
Documents
1
Period of Report
2019-05-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 14496
  Complete submission text file 0001567619-19-012688.txt   17059
Mailing Address 10 ST JAMES AVENUE STE 1700 BOSTON MA 02116
Business Address 6172108300
KLARMAN SETH A (Reporting) CIK: 0000899869 (see all company filings)

State of Incorp.: MA | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-33415 | Film No.: 19877385

Mailing Address 10 ST JAMES AVE SUITE 1700 BOSTON MA 02116
Business Address 10 ST JAMES AVE SUITE 1700 BOSTON MA 02116 617-210-8300
BAUPOST GROUP LLC/MA (Reporting) CIK: 0001061768 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 001-33415 | Film No.: 19877383

Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037
Business Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037 (858) 875-8600
Orexigen Therapeutics, Inc. (Issuer) CIK: 0001382911 (see all company filings)

IRS No.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 10 ST. JAMES AVENUE SUITE 1700 BOSTON MA 02116
Business Address 10 ST. JAMES AVENUE SUITE 1700 BOSTON MA 02116 617-210-8300
Baupost Group GP, L.L.C. (Reporting) CIK: 0001738693 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-33415 | Film No.: 19877384